Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Is xeroderma pigmentosum a contraindication for adjuvant radiation therapy to the breast in the breast conservation setting?
Answer from: Radiation Oncologist at Community Practice
It’s not a contraindication to RT as DSB caused by ionizing RT is not the same as damage caused by exposure to UV rays.
Sign in or Register to read more
8736
Related Questions
How does the extent of DCIS influence eligibility for APBI for invasive breast cancer?
For women with non-autologous breast reconstruction who require PMRT, is it better to radiate an implant or an expander?
Would you offer PMRT when the only indication is a focally positive margin?
Would you consider radiation omission for a patient with a Stage I breast cancer with an elevated Oncotype Dx?
Are there any solutions that allow for expensive dressings (e.g. Mepitel) to be billed to insurance, rather than having to pass the cost on to patients?
How would you approach post-operative radiation in a patient with ER/PR negative Her2 positive, T1c N0 breast cancer originating in the ectopic mammary tissue close to the axilla, treated wide excision followed by APT regimen (weekly paclitaxel plus trastuzumab with trastuzumab for one year)?
How do you respond to a patient who asks "Why do I still need breast radiation after chemotherapy if chemotherapy treats the whole body?"
What volumes would you cover in a young patient with otherwise low risk breast cancer in whom the sentinel node failed to map and ALND was not performed?
What are best practices for oncologists during the national platinum shortage?
In a patient with local recurrence of breast cancer after mastectomy, how would you sequence adjuvant treatment after wide local resection?